Sentinel is used by the U.S. FDA’s Center for Drug Evaluation and Research (CDER) to assess the safety of prescription drugs, including biological therapeutics and generic drugs. Information about CDER and how it makes use of Sentinel in its postmarket safety surveillance programs can be found in the About CDER section. 

Assessments of drugs are posted publically in this section and are available for download.  A complete listing of these assessments can be accessed through an Assessment Database that is searchable by medical product name, health outcome of interest, and study type.